Subcellular real-time imaging of the efficacy of temozolomide on cancer cells in the brain of live mice

Anticancer Research

Volumn 33, Issue 1, 2013, Pages 103-106

  Momiyama, Masashi ^a,b,c   Suetsugu, Atsushi ^a   Chishima, Takashi ^c   Bouvet, Michael ^b   Endo, Itaru ^c   Hoffman, Robert M ^a,b  

^a NtiCancer Inc   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Apoptosis; Brain cancer; GFP; In vivo imaging; Mitosis; Mouse models; RFP; Subcellular dynamics; Temozolomide

Indexed keywords

GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN; TEMOZOLOMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CANCER; BRAIN METASTASIS; CANCER CELL; CANCER SIZE; CONTROLLED STUDY; CRANIOTOMY; CYTOPLASM; GLIOMA; LUNG CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL NUCLEUS; CRANIOTOMY; CYTOPLASM; DACARBAZINE; DIAGNOSTIC IMAGING; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE;

EID: 84873040305     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hoffman RM: The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 5: 796-806, 2005.
2. Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, Chishima T, Shimada H, Moossa AR and Hoffman RM: A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 59: 781-786, 1999.
3. Yang M, Jiang P, An Z, Baranov E, Li L, Hasegawa S, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR and Hoffman RM: Genetically fluorescent melanoma bone and organ metastasis models. Clin Cancer Res 5: 3549-3559, 1999.
4. Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Wessels J and Hoffman RM: A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis. Cell Prolif 42: 75-82, 2009.
5. Hoffman RM: Comment re: Preclinical model of spontaneous melanoma metastasis. Cancer Res 69: 719, 2009.
6. Kimura H, Lee C, Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M and Hoffman RM: UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 110: 1439-1446, 2010.
7. Yamamoto N, Jiang P, Yang M, Xu M, Yamauchi K, Tsuchiya H, Tomita K, Wahl GM, Moossa AR and Hoffman RM: Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res 64: 4251-4256, 2004.
8. Yamauchi K, Yang M, Jiang P, Yamamoto N, Xu M, Amoh Y, Tsuji K, Bouvet M, Tsuchiya H, Tomita K, Moossa AR and Hoffman RM: Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration. Cancer Res 65: 4246-4252, 2005.
9. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R, Yamada A, Sakurada H, Chishima T, Bouvet M, Endo I and Hoffman RM: Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. J Cell Biochem 114: 428-434, 2012.
10. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M and Hoffman RM: Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variablemagnification whole-mouse imaging system. Cancer Res 66: 4208-4214, 2006.
11. Cheng CL, Johnson SP, Keir ST, Quinn JA, Ali-Osman F, Szabo C, Li H, Salzman AL, Dolan ME, Modrich P, Bigner DD and Friedman HS: Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repairdeficient malignant glioma xenograft. Mol Cancer Ther 4: 1364-1368, 2005.
12. Momota H, Nerio E and Holland EC: Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo. Cancer Res 65: 7429-7435, 2005.
13. Baker SD, Wirth M, Statkevich P, Reidenberg P, Alton K, Sartorius SE, Dugan M, Cutler D, Batra V, Grochow LB, Donehower RC and Rowinsky EK: Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res 5: 309-317, 1999.
14. Raymond E, Izbicka E, Soda H, Gerson SL, Dugan M and Von Hoff DD: Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res 3: 1769-1774, 1997.